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Abstract
 
A monolayer of pigment epithelium (PE) lines the iris PE (IPE), ciliary body PE, and retina PE
of the inner eye, an immune-privileged site. These neural crest-derived epithelial cells partici-
pate in ocular immune privilege through poorly defined molecular mechanisms. Murine PE
cells cultured from different ocular tissues suppress T cell activation by differing mechanisms. In
particular, IPE cells suppress primarily via direct cell to cell contact. By examining surface ex-
pression of numerous candidate molecules (tumor necrosis factor receptor [TNFR]1, TNFR2,
CD36, CD40, CD47, CD80, CD86, PD-L1, CD95 ligand, and type I interferon receptor), we
report that IPE cells uniquely express on their surface the costimulatory molecule CD86.
When IPE were blocked with anti-CD86 or were derived from CD80/CD86 (but not CD80)
knockout (KO) mice, the cells displayed reduced capacity to suppress T cell activation. IPE also
failed to suppress activation of T cells in the presence of cytotoxic T lymphocyte–associated an-
tigen 4 (CTLA-4) immunoglobulin or if the T cells were obtained from CTLA-4 (but not
CD28) KO mice. We conclude that iris pigment epithelial cells constitutively express cell sur-
face CD86, which enables the cells to contact inhibit T cells via direct interaction with
CTLA-4. Thus, ocular immune privilege is achieved in part by subversion of molecules that
are usually used for conventional immune costimulation.
Key words: immune privilege • costimulatory molecules • T lymphocytes • inhibition • eye
 
Introduction
 
Ocular immune privilege is a multifactorial mechanism de-
signed evolutionarily to prevent immunogenic inflamma-
tion from disrupting the visual axis and causing blindness
(1–3). Components of this multifactorial mechanism that
have been studied rather extensively include (a) the immu-
nosuppressive properties of aqueous humor (4), and (b) the
capacity of the anterior chamber of the eye to support in-
duction of systemic immune deviation to antigenic material
placed within the eye (5). Less experimental attention has
been devoted to the ocular pigment epithelia, a component
of inner eye tissues derived embryologically from the neu-
ral crest (6). A monolayer of these cells, laden with melanin
pigment, forms a spherical, light-absorbing curtain within
the eye, covering the posterior surface of the iris, lining the
ciliary body that surrounds and extends posteriorly beyond
the lens, and forming the layer just posterior to the neural
retina. In fact, this curtain is only incomplete at the pupil
within the iris, and it is through this aperture that focused
light images pass to the retina where phototransduction
takes place and the process of vision begins.
The diverse but related pigment epithelium (PE)
 
* 
 
of the
iris, the ciliary body, and the retina possess distinct proper-
ties related to their disparate anatomic locations, properties
that are not obviously pertinent to ocular immune privi-
lege. Nonetheless, various laboratories have demonstrated
that the PE of iris, ciliary body, and retina display immu-
nomodulatory features that suggest that this layer of cells
contributes to ocular-immune privilege. Explanted and
cultured iris and ciliary body, as well as PE cells derived
from the ciliary body, have been reported to secrete factors
that are immunosuppressive in vitro (7, 8). Freshly ex-
planted retina PE (RPE), as well as immortalized cell lines
derived from RPE, have been found to secrete immuno-
suppressive factors (9) and express surface molecules, such
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Abbreviations used in this paper:
 
 CBPE, ciliary body pigment epithelium;
CD95L, CD95 ligand; CTLA-4, cytotoxic T lymphocyte–associated an-
tigen 4; IPE, iris pigment epithelium; MMC, mitomycin C; PE, pigment
epithelium; RPE, retina PE.T
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as CD95 ligand (CD95L), which trigger apoptosis among
CD95
 
  
 
T cells (10). If ocular PE contribute to ocular im-
mune privilege, and if loss of privilege results in ocular in-
flammation and blindness, then understanding the contri-
butions that ocular PE make to immune privilege has
therapeutic implications.
Several years ago our laboratory began a systematic analy-
sis of the immunoregulatory properties of PE cells cultured
separately from iris, ciliary body, and retina of mouse eyes.
We reported on the one hand that cultured PE from all
three intraocular tissues were capable of suppressing T cell
activation in vitro (11) and, on the other hand, that T cells
exposed to cultured ocular PE were converted into regula-
tory cells capable of suppressing activation of bystander T
cells in vitro (12). Recently, we discovered that PE cells cul-
tured from the iris inhibited T cell proliferation in vitro by a
contact-dependent mechanism, whereas PE cells cultured
from ciliary body and retina inhibited T cell proliferation
through soluble factors they secreted (13). In an effort to
understand the molecular bases of the immunosuppressive
properties of ocular PE, we have examined the expression
of genes whose products are candidates for participating in
the suppression. We confirm here that iris PE (IPE) cells dif-
fer from ciliary body PE (CBPE) and RPE by suppressing T
cell activation in vitro, primarily by a cell to cell contact-
dependent mechanism. Our experimental evidence indicates
that CD86 (B7-2) is uniquely and constitutively expressed
on the surface of IPE, and that IPE effect contact-dependent
inhibition of T cells through interactions of CD86 with cy-
totoxic T lymphocyte–associated antigen 4 (CTLA-4).
 
Materials and Methods
 
Mice
 
Adult C57BL/6 and BALB/c mice were obtained from our
domestic animal colony. Mice with disrupted genes for CD80, or
both CD80 and CD86, were purchased from The Jackson Labo-
ratory. Mice with disrupted genes for CD28 and CTLA-4 were
obtained from The Jackson Laboratory and provided by J. Allison
(University of California at Berkeley, Berkeley, CA), respectively.
For most of the experiments described, pigmented C57BL/6
mice served as donors of ocular PE cells. For key experimental
observations, parallel studies were also conducted with ocular PE
cells obtained from albino BALB/c mice.
 
Culture Media
 
RPMI 1640 complete medium, used for primary cultures of
IPE and CBPE, was composed of RPMI 1640, 10 mM Hepes,
0.1 mM nonessential amino acids, 1 mM sodium pyruvate, 100
U/ml penicillin, 100 
 
 
 
g/ml streptomycin, 10% FBS (all from
BioWhittaker), and 10
 
 
 
5 
 
M 2-ME (Sigma-Aldrich). DMEM
complete medium, used for primary cultures of RPE cells, was
composed of DMEM, 0.1 mM nonessential amino acids, 100 U/ml
penicillin, 100 
 
 
 
g/ml streptomycin, and 20% FBS.
Cultures of T cells stimulated with anti-CD3 antibodies or in
MLRs were grown in serum-free medium that is composed of
complete medium, except for FBS, and supplemented with 0.1%
BSA (Sigma-Aldrich) and 0.2% insulin, transferrin, selenium cul-
ture supplement (Collaborative Biochemical Products).
 
Preparation of Cultured PE from Iris, Ciliary Body, and Retina
 
PE cells of iris and ciliary body were cultivated separately as
previously described (13). Eyes were enucleated from 6–8-wk-
old male C57BL/6 or BALB/c mice, and cut into two parts (an-
terior and posterior) along a circumferential line just posterior to
the ciliary processes. The lens was removed from the anterior
eyecup and the entire iris and ciliary body tissues were gently
peeled off with a fine forceps. Iris and ciliary body tissues were
separated from each other surgically and incubated in PBS con-
taining 1 mg/ml dispase and 0.05 mg/ml DNaseI (both from
Boehringer) at 37
 
 
 
C for 1 h. Thereafter, iris and ciliary body tis-
sues were triturated progressively, first through 21-gauge and
then 23-gauge needles, to create a single cell suspension. Mono-
dispersed iris and ciliary body cells were washed twice with
RPMI complete medium, and then placed into 6-well plates and
incubated at 37
 
 
 
C in a 5% CO
 
2 
 
atmosphere.
RPE cells were obtained from the posterior part of eyes as de-
scribed above. The neuronal retina was detached and removed,
and the posterior eyecup comprised of RPE, choriocapillaris, and
sclera was incubated in 0.2% trypsin (BioWhittaker) for 1 h at
37
 
 
 
C in a 5% CO
 
2 
 
atmosphere. Thereafter, the eyecup was trans-
ferred to wash medium and RPE cells were peeled off gently as
intact sheets with a fine forceps. RPE sheets were triturated as de-
scribed above to create a single cell suspension, after which the
cells were washed twice with medium, resuspended in DMEM
complete medium, and seeded into 6-well plates and incubated at
37
 
 
 
C in a 5% CO
 
2 
 
atmosphere for 13 d. At the end of this culture
interval, the medium was removed. The RPE cells were washed
with fresh medium devoid of calf serum and used for subsequent
assays. PE cells cultured from iris, ciliary body, and retina were
seeded directly into flat-bottomed 96-well culture plates (2 
 
  
 
10
 
4
 
cells per well) or onto transwell membranes. After overnight in-
cubation in serum-free medium, the cultured PE cells in flat-bot-
tomed wells served as substrates for T cell activation cultures.
Cultured PE cells of these types contain neither CD45
 
  
 
nor
MHC class II
 
  
 
cells.
 
Preparation of Purified T Cells and Description of Assays of T 
Cell Activation
 
For MLRs, spleens were removed from responder (C57BL/6)
and allogeneic stimulator (BALB/c) mice. Responder cell suspen-
sions were pressed through nylon mesh (Immulan™
 
 
 
mouse T cell
kit; Biotex Laboratories) to produce a single cell suspension of
cells that were 
 
 
 
95% CD3
 
 
 
. Stimulator spleen cells were incu-
bated for 20 min at 37
 
 
 
C with 0.05 mg/ml mitomycin C (MMC;
Sigma-Aldrich), washed twice, and then added (2.5 
 
  
 
10
 
5 
 
cells/
well) to wells containing PE cells or not (positive control). Re-
sponder T cells (2.5 
 
  
 
10
 
5 
 
cells/well) were then added and these
cell mixtures were cultured in 200 
 
 
 
l medium at 37
 
 
 
C in a 5%
CO
 
2 
 
atmosphere for 96 h. In syngeneic control MLRs, counts
per minute were always 
 
 
 
3,000.
For anti–CD3-driven T cell activation, purified splenic T cells
were added (2.5 
 
  
 
10
 
5 
 
cells/well) to culture wells containing PE
cells or not. Anti-CD3 antibody (clone 2C11; BD Biosciences)
was added to the wells and the cultures were maintained for 72 h.
For transwell membrane experiments, cultured PE cells were
seeded onto FALCON cell culture inserts (0.4 
 
 
 
m pore size;
Becton Dickinson) and cultured overnight in serum-free me-
dium. Thereafter, the inserts were placed in 24-well culture
plates already containing freshly prepared MLRs or anti–CD3-
driven T cell reactions. After 72- or 96-h incubation the cultures
were assayed for uptake of [
 
3
 
H]thymidine (1 
 
 
 
C/ml for the ter-
minal 8 h of culture), as a measure of cell proliferation. Thymi-T
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dine-pulsed T cells were harvested by automated cell harvester
(Tomtec). Incorporated radioactivity was measured by liquid
scintillation counter, and the amount was expressed in counts
per minute.
 
Flow Cytometry with Anti-Cytokeratin and
Anti-Costimulator Antibodies
 
Cultured IPE, CBPE, and RPE cells were stained with FITC-
labeled anti-pan cytokeratin antibody (clone PCK-26; Sigma-
Aldrich) at the completion of the 14-d primary culture. The cul-
tured cells were fixed and permeabilized with 1
 
 
 
 PermiaFix™
(Ortho Diagnostic Systems Inc.) for 40 min at room temperature,
washed, and then blocked with PBS containing 5% FBS for 10
min, incubated with anti-pan cytokeratin antibody for 40 min at
room temperature, and washed twice. 
 
 
 
90% of the cells proved
to be cytokeratin positive by flow cytometry (IPE 
 
  
 
99%, CBPE 
 
 
 
90%, and RPE 
 
  
 
95%). Similarly fixed and permeabilized cul-
tured PE cells were also stained with FITC-labeled antibodies to
CD80 (clone 16-10A1; BD Biosciences) and CD86 (clone GL1;
BD Biosciences) for flow cytometric analysis.
 
Assay of Cytokine Content within Supernatants
 
To measure cytokine content (IFN
 
 
 
) in supernatants of T cell
cultures, quantitative capture ELISA was used. Culture superna-
tants were collected at 48 h after exposure of T cells to PE cells,
and immediately frozen and stored at 
 
 
 
20
 
 
 
C until used. ELISA
was performed according to the manufacturer’s instructions (BD
Biosciences). Rat mAbs to mouse IFN
 
  
 
(clone R4-6A2; BD
Biosciences) were used as coating antibodies. Biotinylated rat
mAbs to mouse IFN
 
  
 
(XMG1.2; BD Biosciences) were used as
detecting antibodies. The recombinant mouse IFN
 
  
 
used to es-
tablish standards for the assays was purchased from BD Bio-
sciences.
 
Detection of Transcripts within Ocular PE Cells for Pertinent 
Immunomodulatory Molecules
 
Cellular extracts were prepared from cultured PE cells and an-
alyzed by RT-PCR as follows: Cultured PE cells were washed
twice with PBS and then total treated with RNA STAT-60
(TEL-TEST, Inc.). Extracted RNA was treated with RNase-free
DNase (Promega) for 15 min at 37
 
 
 
C, followed by chloroform
extraction. RNA was precipitated by ethanol precipitation and
dried. The RNA was then dissolved with RNase-free water, and
cDNA was synthesized with M-MLV reverse transcriptase
(Promega) according to the manufacturer’s instructions. PCR
was performed by the Hot Start PCR method with AmpliTaq
and AmpliWax (Applied Biosystems). The following conditions
were used: Denaturation at 94
 
 
 
96.5
 
 
 
C for 30
 
 
 
60 s, annealing at
51
 
 
 
62
 
 
 
C for 60 s, and extension at 72
 
 
 
C for 60 s. The products
were subjected to 40 cycles of PCR amplification. The forward
and reverse primers used for GAPDH were to 5
 
 
 
-GGTGAAG-
GTCGGTGTGAACGGA-3
 
  
 
and 5
 
 
 
-TGTTAGTGGGGTC-
TCGCTCCTG-3
 
 
 
, giving an amplification product of 245 bp.
Primers for TNF-R1 (p55) were 5
 
 
 
-CGGGAGAAGAGGGAT-
AGC-3
 
  
 
and 5
 
 
 
-CAACAGCACCGCAGTACCTGA-3
 
 
 
, giving
an amplification product of 537 bp. Primers for TNF-R2
(p75) were 5
 
 
 
-CCGCATCTGTAGCATCC-3
 
  
 
and 5
 
 
 
-CCT-
TGGCATCTCTTTGTAGGC-3
 
 
 
, giving an amplification prod-
uct of 350 bp. Primers for IFN
 
 
 
/
 
  
 
R were 5
 
 
 
-ACCAGGCT-
GCCAGCGGAGAC-3
 
  
 
and 5
 
 
 
-GCCGGGAATCTCGTATT-
GTT-3
 
 
 
, giving an amplification product of 375 bp. Primers for
CD36 were 5
 
 
 
-TCTACGCTGTGTTCGGATCT-3
 
  
 
and 5
 
 
 
-
CACTCCAATCCCAAGTAAGG-3
 
 
 
, giving an amplification
 
product of 536 bp. Primers for CD47 were 5
 
 
 
-GCGAAGT-
GACAGAGTTATCC-3
 
  
 
and 5
 
 
 
-CCGTCACTTCCCTTCAC-
CTA-3
 
 
 
, giving an amplification product of 654 bp. Primers for
CD95L were 5
 
 
 
-CATCACAACCACTCCCACTG-3
 
  
 
and 5
 
 
 
-
CCTCTTCTCCTCCATTAGCA-3
 
 
 
, giving an amplification
product of 312 bp. Primers for CD40 were 5
 
 
 
-CGGCTTCT-
TCTCCAATCAGT-3
 
  
 
and 5
 
 
 
-TAGAAACCCAGGGCGGA-
TTA-3
 
 
 
, giving an amplification product of 1,072 bp. Primers for
CD80 were 5
 
 
 
-GGTATTGCTGCCTTGCCGTT-3
 
  
 
and 5
 
 
 
-
TCCTCTGACACGTGAGCATC-3
 
 
 
, giving an amplification
product of 546 bp. Primers for CD86 were 5
 
 
 
-TCCTG-
TAGACGTGTTCCAGA-3
 
  
 
and 5
 
 
 
-TGCTTAGACGTGCAG-
GTCAA-3
 
 
 
, giving an amplification product of 521 bp. Primers
for PD-L1 were 5
 
 
 
-CGAAGCTTCGCCCACCATGAGGAT-
ATTTGCTGGCATTATATTC-3
 
  
 
and 5
 
 
 
-AGCGGCCGCTT-
ACTTGTCATCGTCGTCCTTGTAGTCCGTCTCCTCGA-
ATTGTGTAGTCCGTCTCCTCGAATTGTGTATCATT-3
 
 
 
,
giving an amplification product of 850 bp (provided by W. Li,
Bascon Palmer Eye Institute, Miami, FL). The PCR products
were electrophoresed in 1, 1.5, and 2% agarose gel and visualized
by staining with ethidium bromide.
 
Immunohistochemistry for Detection of CD80 and CD86 on 
Frozen Sections of Eye Tissues and Cells
 
Immunohistochemical Staining of Frozen Whole Eye Sections.
 
Normal mouse eyes were removed and quick frozen in OCT
embedding compound with dry ice. 10-
 
 
 
m sections were cut
and mounted on microscope slides and then air dried for 60 min.
After fixation in acetone for 10 min, sections were rinsed in 1
 
 
 
PBS three times and incubated for 1 h at room temperature. Sec-
tions were rinsed twice in 1
 
 
 
 PBS and then blocked with 1%
BSA in 1
 
 
 
 PBS for 10 min at room temperature. Antibodies to
CD80 (clone 16-10A1) and CD86 (clone GL1) were added to
the sections at 1 
 
 
 
g/ml in antibody diluent with IHC (BD Bio-
sciences) for 2 h at room temperature. Sections were washed
three times for 2 min in 1
 
 
 
 PBS, followed by the addition of bi-
otin-conjugated mouse anti–hamster IgG for CD80 or biotin-
conjugated donkey anti–rat IgG for CD86 at a 1:200 dilution for
1 h at room temperature. After washing three times for 2 min in
1
 
 
 
 PBS, prediluted streptavidin/horseradish peroxidase (Jackson
ImmunoResearch Laboratories) was applied to each slide and in-
cubated for 30 min at room temperature. After washing three
times for 2 min in 1
 
 
 
 PBS, antibody location was determined
with the addition of DAB substrate (DAB substrate kit; Vector
Laboratories) for 5 min. Color development was stopped by
washing in water for 5 min. After washing three times and fixing,
the slides were examined by light microscopy.
 
Immunohistochemical Staining of Cultured PE Cells.
 
Glass
chamber slides (Nunc) were coated with collagen I. IPE, CBPE,
and RPE cells were cultured on the glass chamber slides for 14 d
and washed twice with 1
 
 
 
 PBS. Some PE cells were treated with
recombinant 100 U/ml IFN . PE cells were then fixed with ace-
tone for 7 min and washed three times with 1  PBS. For Fc
block, purified anti–mouse CD16/CD32 abs (1:200 dilution, Fc 
III/II receptor, clone 2.4G2; BD Biosciences) was added to the
cells for 30 min. The slides were rinsed in 1  PBS three times and
blocking was performed with 2% BSA in 1  PBS. FITC-conju-
gated antibodies CD80 (clone 16-10A1) and CD86 (clone GL1;
each at a 1:50 dilution) were added to the cells for 2 h at room
temperature. After washing three times and fixing, the slides were
examined by fluorescent microscopy. Isotype controls included
purified hamster IgG for CD80 (BD Biosciences) and purified rat
IgG for CD86 (BD Biosciences) that used both staining.T
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Blockade of CD80 and/or CD86 During Exposure of T Cells to 
Cultured Ocular PE Cells
Anti–mouse CD80 and/or CD86 monoclonal antibodies were
included in cultures in which cultured ocular PE cells were
present during stimulation of T cells with anti-CD3 antibodies.
Purified T cells (2.5   105 cells/well) were stimulated with 1  g/
ml anti-CD3 antibodies and cultured for 72 h with or without
cultured IPE, CBPE, and RPE. As controls, purified hamster IgG
(for CD80; BD Biosciences) and purified rat IgG (for CD86; BD
Biosciences) were added to appropriate cultures. In some experi-
ments, CTLA-4–Ig proteins were included in cultures in which
cultured ocular PE cells were present during stimulation of T
cells with anti-CD3 antibodies. Cultured PE cells were added in
the presence of graded amounts (from 0 to 5  g/ml) of CTLA-
4–Ig in a dose-dependent manner. In MLRs, responder spleen
cells (C57BL/6, 2.5   105 cells/well) were cultured with MMC-
treated stimulator spleen cells (BALB/c, 2.5   105 cells/well) in
the presence or absence of cultured PE cells for 96 h.
Statistical Evaluation of Results
Each experiment was repeated at least twice with similar re-
sults. All statistical analyses were conducted with Student’s t test.
Values were considered statistically significant if P   0.05.
Results
Differential Capacity of Cultured Ocular PE to Inhibit T Cell
Proliferation across Transwell Membranes. The diverse ocu-
lar PE cells exist in components of the eye (iris, ciliary
body, and retina) with distinct functions, and in each loca-
tion T cells from the blood pass between adjacent PE cells
in monolayers to enter the inner eye. To assay the role of
cell to cell contact in PE-dependent suppression of T cell
activation, ocular PE cells from iris, ciliary body, and retina
of eyes of C57BL/6 mice were cultured separately for 14 d
in 24-well culture plates. Transwell inserts were then
placed in these wells and the transwell contained C57BL/6
T cells plus anti-CD3, or MLRs composed of responder
C57BL/6 T cells and MMC-treated BALB/c spleen cells as
stimulators. T cell proliferation was assessed by [3H]thymi-
dine incorporation at 72 (anti-CD3) or 96 h (MLRs). As
revealed in Fig. 1, RPE cells suppressed anti–CD3-driven
T cell proliferation readily across a transwell membrane, in-
dicating that soluble factors released from the PE cells in
the insert were able to diffuse through the membrane and
act on the responding T cells in the culture below (Fig. 1
C). By contrast, IPE cells largely failed to suppress T cell
proliferation across the transwell membrane, indicating that
cell to cell contact is important when IPE mediate suppres-
sion of T cell activation (Fig. 1 A). CBPE cells assumed an
intermediate suppressing capacity, retaining a modest, but
significant, capacity to suppress T cell activation across the
transwell membrane (Fig. 1 B). The effects of PE cells on T
cell proliferation was similar whether the T cell stimulation
was mediated by anti-CD3 antibodies, or by exposure to
allogeneic spleen cells (not depicted). Comparable results
were obtained when PE cells were harvested from eyes of
BALB/c mice (not depicted). These results strongly suggest
that cultured IPE cells use a contact-dependent mechanism
in suppressing T cell activation. The results do not exclude
a similar mechanism for RPE and CBPE, however, be-
cause the capacity of these cells to secrete immunosuppres-
sive soluble factors has the potential to eclipse our ability to
detect a contact-dependent suppressive mechanism. The
finding that CBPE suppressed less well when separated
from target T cells by the transwell membrane suggests that
CBPE probably use a cell contact inhibitory mechanism in
addition to soluble immunosuppressive factors they secrete.
The subsequent experiments describe our attempts to iden-
tify the interacting cell surface molecules that (a) are differ-
entially expressed on IPE as they suppress T cell activation
almost exclusively via a cell contact-dependent mechanism,
and (b) are expressed on the inhibited T cells.
Expression in Cultured Ocular PE Cells of Genes Encoding
Candidate Cell Surface Molecules That Could Mediate Contact-
dependent Suppression of T Cell Activation. PE cells were
cultured from iris, ciliary body, and retina of eyes of
C57BL/6 mice. After 14 d, the cells were harvested and
mRNA was extracted. Using RT-PCR, the mRNA of
each cell type was probed for transcripts of the following
candidate molecules: TNFR1, TNFR2, type I IFNR
(IFN /  receptor), CD95L, CD36, CD40, CD47, CD80
Figure 1. Influence of transwell mem-
branes on capacity of cultured ocular PE to
suppress anti-CD3 T cell activation. PE
from C57BL/6 iris (A), ciliary body (B),
and retina (C) were grown in 24-well cul-
ture plates. Transwell cell culture inserts
were placed in these wells, and syngeneic T
cells plus anti-CD3 antibodies were placed
therein. [3H]thymidine was added 8 h be-
fore the termination of culture at 72 h.
Mean counts per minute for triplicate cul-
tures are presented   SEM. Differences of
means of T cell proliferation in the presence
or absence of PE cells are compared. *, P  
0.05; **, P   0.005; ***, P   0.0005; NS,
not significant.T
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(B7-1), CD86 (B7-2), and PD-L1 (B7-H1). The results of
this experiment are presented in Fig. 2. None of the cul-
tured PE cell types expressed the genes for CD95L, CD40,
or PD-L1, whereas all of the cell types contained tran-
scripts for TNFR1, TNFR2, type I IFNR, CD36, CD47,
and CD80. Only in the case of CD86 did we detect differ-
ential expression of transcripts among the three ocular PE
cell types. CD86 transcripts were easily detected in cul-
tured IPE and to a lesser extent in CBPE, but not in RPE.
Thus, CD86 emerged as a candidate molecule in the sup-
pression of T cell activation achieved by contact exposure
to IPE.
Influence of Antibodies to CD80 and CD86 on Capacity of
Ocular PE Cells to Suppress T Cell Activation In Vitro. To
determine whether CD80 and/or CD86 is involved in
suppression of T cell activation by IPE cells, anti–CD3-
driven T cell activation cultures were performed in wells
containing a monolayer of cultured IPE, CBPE, or RPE
as described above. In some wells, anti-CD80 or anti-
CD86 antibodies were added alone or in combination. T
cell proliferation was assessed as before, and the results are
displayed in Fig. 3. In cultures containing IPE plus anti-
CD86 antibodies alone, or anti-CD80/anti-CD86 anti-
bodies, T cell proliferation was significantly greater than
in cultures to which isotype control antibodies were
added (Fig. 3 A). In cultures containing IPE plus anti-
CD80 antibodies alone, a small increase in T cell prolifer-
ation was observed. By contrast, neither anti-CD80 nor
anti-CD86 antibodies relieved the profound suppression
observed in cultures in which T cells were exposed to
CBPE (Fig. 3 B) or RPE (Fig. 3 C). Parallel experiments
conducted with ocular PE harvested from BALB/c mice
yielded similar results (not depicted). These findings sup-
port the hypothesis that IPE suppress T cell activation via
a CD86-dependent mechanism. The results bearing on a
comparable role for CD80 are less impressive, although
CD80 cannot on the basis of these findings be excluded
from participating in IPE-dependent T cell suppression.
Anti-CD86 antibodies did not reverse completely the
suppression mediated by IPE, even when higher antibody
concentrations were used. We infer that IPE use surface
molecules in addition to CD86 in mediating suppression
of T cell activation.
Figure 2. Survey of gene expression of candidate-suppressive cell sur-
face molecules on PE cells cultured from iris, ciliary body, and retina.
mRNA was extracted from IPE, CBPE, and RPE cells after 14 d of cul-
ture, reverse transcribed, and amplified by PCR. PCR products were
electrophoresed in 1, 1.5, and 2% agarose gel and visualized by staining
with ethidium bromide.
Figure 3. Capacity of neutralizing antibodies to CD80 and CD86 to
prevent suppression of T cell activation by cultured PE cells. Anti-CD3
stimulation of purified C57BL/6 T cells was performed as described in
the legend to Fig. 1. Cultured IPE (A), CBPE (B), or RPE cells (C) were
added in the presence or absence of 1  g/ml anti-CD80 and/or anti-
CD86 antibodies. As isotype controls, purified hamster IgG for CD80 and
purified rat IgG for CD86 were used. After 72 h of incubation, the cul-
tures were assayed for uptake of [3H]thymidine. Mean counts per minute
for triplicate cultures are presented   SEM. Differences of means of T
cell proliferation in the presence of PE cells with and without anti-CD80
or anti-CD86 antibodies are compared. *, P   0.05; **, P   0.005.T
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CD80 and CD86 Expression on Cultured Ocular PE Cells
Detected by Flow Cytometry. Because cultured PE cells ex-
pressed transcripts for CD80 and/or CD86, and because
antibodies directed at CD86 partially alleviated the suppres-
sion mediated by IPE, we next examined by flow cytome-
try the extent to which cultured PE cells expressed CD80
and CD86. After 14 d of primary culture, IPE, CBPE, and
RPE cells were harvested and labeled with FITC-conju-
gated antibodies directed at CD80 or CD86, and were ana-
lyzed by flow cytometry. The results of a representative ex-
periment (of two) are presented in Fig. 4. CD80 was
expressed on the majority of cultured IPE and CBPE, as
well as on a large minority of RPE cells. By contrast, CD86
was expressed on a very high proportion of IPE cells, but
on far fewer CBPE and RPE cells. The hypothesis that IPE
cells mediate suppression of T cell activation via a CD86-
dependent contact mechanism is supported by these data.
Expression of CD80 and CD86 Genes and Proteins in
Freshly Procured Ocular PE and Tissues. Cells cultured from
living tissues offer a convenient approach to the study of those
tissues, but cultured cells often express molecules and adopt
functional properties that are at variance with the intact tis-
sue. We wished next to determine whether CD80 and
CD86 are expressed on PE cells freshly obtained from iris,
ciliary body, and retina. To that end, iris, ciliary body, and
retina were harvested separately from eyes of adult mice.
PE cells cultured from all three ocular tissues for 14 d were
also prepared. mRNA was extracted from each of these tis-
sue samples and from cultured cells, and then subjected to
RT-PCR with primers for CD80 (Fig. 5 A), CD86 (B),
PD-L1 (C), CD40 (D), or GAPDH (E). As revealed in Fig.
5, transcripts of CD80 and CD86 were detected in freshly
obtained iris tissues. Transcripts for CD40 and PD-L1 were
not detected in any ocular tissues containing PE or in cul-
tured PE cells. However, transcripts for PD-L1 were in-
ducibly detected in IFN -treated PE cells (Fig. 5 C). These
results confirm that the genes for the costimulatory mole-
cules CD80 and CD86 are open in both fresh and cultured
PE cells. To further explore the expression of CD80 and
CD86 in noncultured ocular tissues, frozen sections were
prepared from eyes of C57BL/6 and BALB/c mice and
subjected to immunohistochemical analysis using reagents
that detect CD80 and CD86. As summarized in Table I,
CD86 was detected in corneal epithelium (but not endo-
thelium) in iris, ciliary body, lens, and RPE (but not in
neural retina). A similar distribution pattern was observed
for CD80, although the intensity of CD80 staining was
much lower in epithelium of cornea and lens. The pattern
of CD80 and CD86 expression on freshly obtained normal
ocular tissues implies that expression of these costimulatory
molecules is constitutive.
Similar immunohistochemical studies were performed
on primary cultures of PE cells from iris, ciliary body, and
retina. As summarized in Table II, all three PE cell types
expressed CD80. IPE cells expressed easily detectable
CD86 that appeared to be diffuse within the cytoplasm and
on the cell surface. Little CD86 expression was detected in
or on CBPE. CD86 was expressed in RPE, but the distri-
bution of label was restricted to cytoplasmic granules. The
intracytoplasmic localization of CD86 in cultured RPE ob-
served in these studies helps to explain why flow cytomet-
ric analysis of cultured RPE revealed so few cells with pos-
itive surface staining for this molecule. These results suggest
further that it is surface expression of CD86 that is relevant
to the ability of IPE cells to inhibit T cell activation by a
contact-dependent mechanism.
Capacity of Cultured Ocular PE from Mice with Disrupted
CD80   CD86 Genes to Inhibit Anti–CD3-driven T Cell
Proliferation and Production of Cytokine In Vitro. If CD86
plays an important role in mediating suppression of T cell
activation by IPE (and not CBPE and RPE), it is worth-
while to study mice in which the genes for CD80 and
CD86 are disrupted. Two types of mice were available for
our study: CD80 KO mice and mice in which both the
CD80 and the CD86 genes had been disrupted. PE cells
were cultured from iris, ciliary body, and retinas of these
mice, as well as C57BL/6 wild-type mice. The cultured
cells were then used as substrates for C57BL/6 T cells stim-
ulated with anti-CD3 antibodies or with allogeneic spleen
Figure 4. Detection of B7 molecules on cultured PE cells by flow cy-
tometry. IPE (BALB/c and C57BL/6), CBPE (C57BL/6), and RPE cells
(C57BL/6) were cultured on 6-well plates for 14 d. Thereafter, the con-
fluent cells were triturated several times through 21-gauge and then 23-
gauge needles to create a single cell suspension. PE cells were incubated
with FITC-conjugated antibodies: anti-CD80, anti-CD86, or purified
hamster IgG as isotype control for 1 h at room temperature. After wash-
ing and fixation, the cells were analyzed by flow cytometry. Percentages
in upper right corners indicate positive cells. Number in parenthesis indi-
cate mean fluorescence index.T
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167 Sugita and Streilein
cells. T cell proliferation and IFN  production were as-
sayed as described above. T cells exposed to cultured IPE
from CD80/CD86 double KO donors proliferated in re-
sponse to anti-CD3 (Fig. 6 A) and allogeneic spleen cells
(not depicted) to a much higher degree than T cells ex-
posed to cultured wild-type IPE cells. No similar relief of
suppression was observed when T cells were stimulated and
exposed to cultured CBPE or RPE from double KO do-
nors (Fig. 6, B and C). Very similar results were obtained
when the concentration of IFN  in supernatants was as-
sayed. CD80/CD86 KO IPE cells suppressed IFN  pro-
duction by anti–CD3-stimulated T cells much less well
than CBPE and RPE cells from the same KO donors (not
depicted). T cells exposed to cultured IPE from CD80 KO
donors displayed a modest, but significant increase in pro-
liferation in comparison to T cells exposed to cultured
wild-type PE cells (not depicted), but no comparable relief
of suppression was observed in the presence of CBPE or
RPE from CD80 KO donors. In previous experiments
(13), ocular PE cells cultured from eyes of mice with defec-
tive genes encoding CD95L, TNFR1 (p55), and TNFR2
(p75) suppressed T cell activation as well as PE cells cul-
tured from wild-type mouse eyes, excluding the products
of these genes as relevant to the suppressive activities of oc-
ular PE cells. It should be noted that IPE from CD80/
CD86 KO donors did not completely fail to suppress T cell
activation. Compared with the responses of the positive
control T cells (stimulated in the absence of cultured PE
cells), IPE from CD80/CD86 KO donors suppressed T cell
activation to a much lesser extent than that achieved by
IPE from wild-type donors (Fig. 6 A).
Capacity of CTLA-4–Ig to Interfere with Suppression of T
Cell Activation by IPE. CD86 is a costimulation molecule
that is expressed on APCs and through binding to CD28
provides a key activation signal to T cells. CD86 also binds
Figure 5. Detection of mRNA expression of costimula-
tory molecules in ocular PE. mRNA, extracted from cul-
tured IPE, CBPE, and RPE cells with or without 100
U/ml recombinant IFN-  (samples 1–6), and from freshly
obtained mouse iris, ciliary body, and retina (samples 7–9),
was reverse transcribed and amplified by PCR using prim-
ers for (A) CD80 (B7-1), (B) CD86 (B7-2), (C) PD-L1
(B7-H1), (D) CD40, and (E) GAPDH. PCR products
were electrophoresed in 1.5% agarose gel and visualized by
staining with ethidium bromide.
Table I. Detection of CD80 and CD86 on Freshly Obtained 
Ocular Tissues
Tissues CD80 (B7-1) CD86 (B7-2)
Corneal epithelium   
Corneal stroma (keratocytes)   
Corneal endothelium   
Iris   
Ciliary body   
Lens epithelium   
Lens fiber cells   
Neural retina   
RPE   
Eyes of BALB/c mice were enucleated, snap frozen, sectioned, placed
on glass slides, fixed with acetone, and stained with antibodies to CD80,
CD86, and isotype IgG controls, followed by biotin-conjugated sec-
ondary anti-antibodies, and then developed with streptavidin/horse-
radish peroxidase and the DAB substrate. Specimens were examined by
light microscopy. Staining of tissues and cells with DAB is indicated
with  .
Table II. Detection of CD80 and CD86 on Cultured Ocular
PE Cells
PE cell types CD80 (B7-1) CD86 (B7-2)
Iris   
Iris, treated with IFN        
Ciliary body   
Ciliary body, treated with IFN      
Retina   ( )a
Retina, treated with IFN     ( )a
aStaining within cytoplasmic granules without evidence of cell surface
staining.
Extent of staining is presented semiquantitatively as  ,  , or   . 
PE cells from iris, ciliary body, and retina were cultured for 14 d,
washed, and then incubated overnight in serum-free medium, with or
without 100 U/ml IFN . The cells were then removed, fixed with
acetone, and stained with FITC-conjugated anti-CD80 or anti-CD86
antibodies, and examined by fluorescent microscopy.T
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CTLA-4 on T cells, in which case the T cells are negatively
signaled and acquire anergic and even regulatory proper-
ties. CTLA-4–Ig is a fusion protein that binds to CD86
with very high affinity and is able to thwart CD28-depen-
dent T cell activation. In the following experiments, we
tested the effect of CTLA-4–Ig on the activation of T cells
exposed in vitro to IPE and stimulated with anti-CD3. As
before, purified splenic T cells were placed in culture wells
containing cultured IPE and stimulated with anti-CD3 an-
tibodies in the presence of CTLA-4–Ig over a concentra-
tion range of 5.0–0.001  g/ml. T cell proliferation was
measured at 72 h by triturated thymidine uptake. As the re-
sults displayed in Fig. 7 reveal, above a concentration of 0.5
 g/ml CTLA-4–Ig, T cells exposed to IPE underwent sig-
nificant levels of proliferation. In addition, IPE cells failed
to suppress T cell activation with allogeneic spleen cells
(not depicted). Similar experiments performed with anti–
CD3-stimulated T cells exposed to CBPE or RPE in the
presence of CTLA-4–Ig failed to reveal T cell proliferation
(not depicted). These findings indicate that blocking of in-
teractions between CD86 on IPE cells and coreceptors on
T cells partially relieves the contact-dependent suppression
mediated by IPE cells.
Identification of Costimulation Receptor on T Cells that Ac-
counts for CD86-dependent Suppression. Next, we inquired
into the nature of the costimulation receptor that is present
on T cells and which upon binding to CD86 delivers a
negative signal for activation. For these experiments we
used mice with disrupted genes for CD28 or CD152
(CTLA-4). PE cells were cultured as before from iris, cili-
ary body, and retina and placed in culture wells. Purified
splenic T cells were then prepared from CTLA-4 / ,
CD28 / , and wild-type control mice and added to these
wells. The T cells were then stimulated with anti-CD3 an-
tibodies at two different concentrations, 0.5 and 1.0  g/
ml, and proliferation was assessed by triturated thymidine
uptake. CD28 /  T cells were as profoundly suppressed as
wild-type T cells when exposed to IPE, CBPE, and RPE
(Fig. 8). By contrast, CTLA-4 /  T cells proliferated when
exposed to IPE, but not when exposed to CBPE and
RPE. In fact, T cells from CTLA-4 KO mice that were
stimulated with 0.5  g/ml anti-CD3 in the presence of
IPE cells proliferated almost to the same extent as did sim-
ilar T cells exposed to anti-CD3 in the absence of IPE.
Together, these results indicate that IPE constitutively ex-
press CD86 and this molecule binds directly to CTLA-4
on T cells, thereby changing the T cells’ functional pro-
gram and suppressing their susceptibility to activation
through the T cell receptor.
Discussion
Recently published data (11–13) and our current results
indicate that T lymphocytes that encounter PE of the inter-
Figure 6. Capacity of cultured PE cells
from donors deficient in CD80 plus CD86
expression to inhibit T cell proliferation.
Purified C57BL/6 T cells (2.5   105 cells/
well) were stimulated with 1  g/ml anti-
CD3 antibody and cultured for 72 h in the
presence or absence of cultured IPE (A),
CBPE (B), or RPE (C) obtained from eyes
of CD80/CD86 KO or wild-type (C57BL/6)
mice. After 72 h, the cultures were assayed
for uptake of [3H]thymidine. Mean counts
per minute for triplicate cultures are pre-
sented   SEM. Differences of means of T
cell proliferation in the presence of wild-
type or CD80/CD86 KO PE cells are com-
pared. **, P   0.005, compared with two
groups. NS, not significant.
Figure 7. Influence of CTLA-4–Ig on
suppression of T cell activation by ocular
PE. PE cells were cultured from iris, ciliary
body, and retina of C57BL/6 mice. IPE
served as substrates for purified T cells stim-
ulated with anti-CD3 antibodies in the
presence of varying concentrations of
CTLA-4–Ig. Cultures were terminated at
72 h and [3H]thymidine incorporation was
assessed. Mean counts per minute for tripli-
cate cultures are presented   SEM. Differ-
ences of means of T cell proliferation in the
presence or absence of CTLA-4–Ig are
compared. *, P   0.05.T
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nal ocular compartments fail to respond to activation stim-
uli by differentiating into effector cells, i.e., the T cells fail
to proliferate and secrete proinflammatory cytokines such
as IFN . Instead, T cells that have experienced such an en-
counter differentiate into regulator cells that are capable of
suppressing the activation of bystander T cells (12). The
failure of T cells exposed to ocular PE cells to express effec-
tor functions, and their acquisition of a regulatory pheno-
type, support the view that ocular PE cells act locally on T
cells to prevent the expression of immunogenic inflamma-
tion within the eye. In that regard, our results reveal that
unique expression of the immune costimulation molecule
CD86 (B7-2; reference 14) on IPE enables these cells to al-
ter the functional properties of T cells they encounter, and
that CD152 (CTLA-4) is the coreceptor on T cells with
which CD86 interacts.
Activation of T lymphocytes by professional APCs oc-
curs through the delivery of two distinctly different, but es-
sential signals (15). Signal 1, presented by APCs as immu-
nogenic peptides displayed on class I or II MHC molecules,
is detected by the T cell receptor for antigen, and accounts
for the antigen specificity of T cell activation. Signal 2, pre-
sented by APCs, provides costimulation that is mediated by
cell surface molecules, such as CD80, CD86, and CD40,
and/or by secreted cytokines, such as IL-12. Responding T
cells receive Signal 2 via cell surface ligands such as CD28
and CTLA-4, and cytokine receptors, such as IL-12R.
Nonprofessional APCs that express Signal 1 often fail to ac-
tivate T cells properly because the former cells typically
lack expression of costimulation molecules (Signal 2). Con-
sequently, responding T cells display an anergic phenotype,
or simply fail to be aroused (16).
Although ocular PE cells fit into the category of nonpro-
fessional APCs, our results indicate that, paradoxically, oc-
ular PE cells constitutively express molecules defined im-
munologically as costimulators: CD80 and CD86. We
report that the genes encoding CD80 and CD86 are con-
stitutively open in both freshly explanted as well as cultured
PE cells of iris, ciliary body, and retina. Moreover, CD80
was found to be expressed where PE cells reside within in-
tact iris, ciliary body, and retina, and on the surface of
freshly prepared and cultured PE cells. CD86, by contrast,
was expressed on a very high proportion of cultured IPE,
but at much lower frequencies among cultured CBPE and
RPE. This differential pattern of CD86 expression among
the three types of ocular PE cells is relevant to the means
by which these different cell types suppress T cell activation
in vitro.
Whereas cultured CBPE and RPE secrete soluble factors
that suppress T cell activation in vitro, IPE do so only very
poorly. Instead, IPE suppress T cell activation primarily via
a mechanism that implies direct contact between IPE and
T cells, i.e., not across a transwell membrane. In our exper-
iments, unique expression of CD86 on IPE correlated pos-
itively with the capacity of anti-CD86 antibodies to allevi-
ate suppression of T cell activation mediated by IPE.
Moreover, IPE derived from eyes of CD80/CD86 KO
mice were far less able to suppress T cell activation in vitro
than wild-type IPE. IPE from CD80 KO mice were almost
as immunosuppressive for T cells as wild-type IPE. Impor-
tantly, CBPE and RPE from both CD80 KO and CD80/
CD86 KO mice proved as effective at suppressing T cell
activation in vitro as wild-type CBPE and RPE cells. This
laboratory has reported elsewhere that antibodies capable of
Figure 8. Capacity of ocular PE to sup-
press activation of T cells from mice with
disrupted CD28 and CTLA-4 (CD152)
genes. PE were cultured from iris, ciliary
body, and retina of C57BL/6 mice and used
as substrates for purified T cells prepared
from the spleens of 22-d-old wild-type
mice, 22-d-old CTLA-4 /  mice, and
6-wk-old CD28 /  mice. The T cells were
stimulated with anti-CD3 antibodies at
concentrations of (A) 0.5 and (B) 1.0  g/
ml. Cultures were terminated at 72 h and
[3H]thymidine incorporation was assessed.
Mean counts per minute for triplicate cul-
tures are presented   SEM. Differences of
means of T cell proliferation in the presence
or absence of PE cells are compared. *, P  
0.05; **, P   0.005; ***, P   0.0005; NS,
not significant.T
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neutralizing CD40, CD154, CD48, and ICAM-1 failed to
relieve suppression mediated by ocular PE cells (13). In ag-
gregate, the evidence presented here indicates that IPE cells
suppress T cell activation largely, if not completely,
through their surface expression of CD86.
Although CD86 expression on IPE cells accounts for
much of their ability to suppress T cell activation, other
molecules must also be involved. IPE from mice with a dis-
rupted CD86 gene and IPE from wild-type mice in the
presence of anti-CD86 antibodies still achieved partial sup-
pression of T cell activation in vitro. In this regard, our re-
sults suggest that CD80 on IPE might also make a minor
contribution to this suppression. Our survey of expression
of candidate molecules and genes that might also mediate
suppression tends to exclude from further consideration
TNFR1, TNFR2, type I IFNR, CD36, CD40, CD47,
CD95L, and PD-L1, an inhibitory member of the CD80/
CD86 family of costimulation molecules (17). In an effort
to discover the other molecules responsible for contact-
dependent suppression by IPE, we are resorting to micro-
chip gene array technology.
Because all mature T cells express CD28, this ligand was a
prime suspect (18) for interacting with CD86 on IPE. Yet,
the experiments reported here indicate that CTLA-4 rather
than CD28 is the relevant coreceptor for CD86 that leads to
suppression of T cell activation. This outcome is consistent
with the view that activation of T cells through CTLA-4
delivers negative signals to the cells, resulting in anergy (19),
apoptosis (20), and even acquisition of regulatory function
(21–23). As mentioned in the Introduction, T cells that en-
counter cultured IPE cells in vitro are not only inhibited
from proliferating, but they also acquire regulatory proper-
ties. Studies are in progress to determine whether interac-
tions between CD86 on IPE and CTLA-4 on T cells also
lead to the conversion of T cells into regulators.
It is worth pointing out that naive T cells that receive an
activation stimulus (anti-CD3 or allogeneic spleen cells) in
the presence of cultured PE cells do not differentiate into
Th1 cells: they failed to secrete IFN . It is pertinent to
thoughts of immunoregulation to point out that the re-
sponding T cells also fail to differentiate into Th2 cells:
they failed to secrete IL-4 and IL-10 (24). Thus, T cells
that encounter ocular PE cells are not merely deflected to-
ward the Th2 pathway of differentiation. Rather, T cells
that interact with ocular PE appear to take a third differen-
tiation pathway, one in which they can regulate and inhibit
the activation of bystander T cells in the local microenvi-
ronment. In a similar manner, T cells activated in the pres-
ence of aqueous humor differentiate into regulator cells
that do not express the Th2 phenotype (25). Previous stud-
ies have indicated that T cells that have encountered cul-
tured ocular PE cells in vitro secrete TGF  (12). We are
eager to understand the relationship between CD86-
expressing IPE cells and responding T cells that use TGF 
to regulate bystander T cells.
The finding of constitutive expression of CD80 and
CD86 on various tissues of the eye is unexpected, and the
expression of these costimulation molecules on cells of
nonhematopoietic lineage is, to our knowledge, unprece-
dented. In addition to their expression on neural crest-
derived, ocular PE, CD80 and CD86 are also expressed on
epithelia of cornea and lens, both of which are derived
from nonneural ectoderm. Thus, embryologic origin can-
not explain the distinctive and unexpected pattern of ex-
pression of CD80 and CD86 in the eye. A similar pattern
of expression has been reported for CD95L, another mole-
cule originally thought to be expressed exclusively on cells
of the immune system (26). The expression of CD95L on
certain cells of the testis (27), the eye (28), the placenta
(29), and the brain (30), and our current demonstration
that CD80 and CD86 are constitutively expressed on ocu-
lar PE lead us to propose that immune privileged tissues
and sites hijack and subvert for their own special physio-
logic purposes molecules used otherwise by the immune
system to carry out its normal physiologic functions. Our
discovery of expression of CD80 and CD86 on certain cells
of the eye extends the list of immune system–related mole-
cules used for the creation and maintenance of tissue-
restricted immune privilege.
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